Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analytical Tool - Angiogenesis in Oncology' returned 332 results - Page 1 of 17  FEATURED RESULTS Antibody Drug Target Atlas in Oncology Cancer Diagnostic Testing World Markets Drug Delivery in Cancer - Technologies, Markets and Companies A Dictionary of Human Oncology: A Concise Guide to Tumors An Atlas of Gynecologic Oncology, Third Edition   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Analytical Tool - Peptides in Oncology   Bioseeker, Nov 2011 "Analytical Tool- Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in peptide drug development for the treatment of cancer Analytical Tool - Antibodies and Peptides in Oncology   Bioseeker, Nov 2011 "Analytical Tool – Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development Analytical Tool - Apoptosis in Oncology   Bioseeker, Dec 2011 "Analytical Tool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer Analytical Tool - Protein Kinase Inhibitors in Oncology   Bioseeker, Feb 2011 Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase Analytical Tool - Cancer Immunotherapy   Bioseeker, Feb 2011 "Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer Analytical Tool - Cancer Therapeutic Antibodies   Bioseeker, Sep 2011 "Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Nov 2011, Pages: 906 in Oncology 6.6 The Drug-Target Competitive Landscape 6.7 Protein Expression Levels of Identified Targets of Peptide Drugs in Oncology 6.8 Pathway Assessment of Peptide Drugs in Oncology 6.8.1 Tools The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Sep 2011, Pages: 1944 of Antibody Drugs in Oncology 6.8.1 Tools for Analysis of Cancer Pathways 6.8.2 Pathway Assessment 7 Emerging New Products to Established Ones: Drug Target Strategies of Antibody Drugs in Oncology Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline   Bioseeker, June 2010, Pages: 596 .7 Protein Expression Levels of Identified Targets of Cancer Peptide Drugs 6.8 Pathway Assessment of Peptide Therapeutic Targets in Oncology 6.8.1 Tools for Analysis of Cancer Pathways 6.8.2 Pathway Commercializing Apoptotic Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Dec 2011, Pages: 1617 Drugs in Oncology 6.8.1 Tools for Analysis of Cancer Pathways 6.8.2 Pathway Assessment 7 Emerging New Products to Established Ones: Drug Target Strategies of Apoptotic Drugs in Oncology Protein Kinase Therapeutics in Oncology - Where to Commercialize?   Bioseeker, Oct 2009, Pages: 1442 -Out Table 293: ToolGen's Included Protein Kinase Drugs in Oncology and Competitive Fall-Out Table 294: TopoTarget's Included Protein Kinase Drugs in Oncology and Competitive Fall-Out Table 295: UCB Triple Analysis: Colorectal Cancer, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3579 (Peptides). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology Triple Analysis: Leukemia, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3670 ). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes Triple Analysis: Lung Cancer, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3846 (Peptides). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology Triple Analysis: Lymphoma, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3477 ). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes Triple Analysis: Melanoma, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3300 ). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes Triple Analysis: Prostate Cancer, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3361 (Peptides). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology Triple Analysis: Apoptosis, Cancer Vaccines and Peptides   Bioseeker, Dec 2011, Pages: 3182 of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies   Bioseeker, June 2006 "Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody R Triple Analysis: Colorectal Cancer, Antibodies and Peptides   Bioseeker, Nov 2011, Pages: 3906 is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network